Long-term effect of IFNβ1b treatment on the spontaneous and induced expression of IL-10 and TGFβ1 in MS patients

Journal of the Neurological Sciences

Volumn 179, Issue 1-2, 2000, Pages 43-49

  Gayo, Abel ^a   Mozo, Lourdes ^a   Suárez, Ana ^a   Tũon, Alberto ^a   Lahoz, Carlos ^a   Gutiérrez, Carmen ^a  

^a UNIVERSITY OF OVIEDO   (Spain)

Author keywords

IL 10; Interferon ; mRNA; Multiple sclerosis; TGF

Indexed keywords

CYTOKINE; INTERFERON BETA SERINE; INTERLEUKIN 10; MESSENGER RNA; METHYLPREDNISOLONE; MITOGENIC AGENT; PREDNISONE; PROTEIN; TRANSFORMING GROWTH FACTOR BETA1;

ARTICLE; BLOOD LEVEL; BLOOD SAMPLING; CELL CULTURE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; DOSE TIME EFFECT RELATION; DRUG MECHANISM; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNITY; LONG TERM CARE; MONONUCLEAR CELL; MULTIPLE SCLEROSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; RELAPSE; REMISSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SUPERNATANT;

DISEASE PROGRESSION; HUMAN; INTERFERON-BETA; INTERLEUKIN-10; LEUKOCYTES, MONONUCLEAR; MULTIPLE SCLEROSIS, RELAPSING-REMITTING; RECURRENCE; RNA, MESSENGER; SUPPORT, NON-U.S. GOV'T; TIME FACTORS; TRANSFORMING GROWTH FACTOR BETA; TREATMENT OUTCOME;

EID: 0034306178     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-510X(00)00369-5     Document Type: Article

References (18)

1. Interferon beta-1b in the treatment of multiple sclerosis: final outcome of the randomized controlled trial
2. Interferon beta-1b is effective in relapsing-remitting multiple sclerosis: II MRI analysis of results of a multicenter, randomized, double-blind, placebo controlled trial
3. Biological effects of interferons: relevance to multiple sclerosis
4. Interferon beta in multiple sclerosis
5. Interferon β1b treatment decreases tumor necrosis factor-α and increases interleukin-6 production in multiple sclerosis
6. Interferon-gamma-producing blood lymphocytes are decreased by interferon beta therapy in patients with multiple sclerosis
7. Interferon beta decreases T cell activation and nterferon gamma production in multiple sclerosis
8. Interferon-gamma secreting cells in multiple sclerosis patients treated with interferon-beta 1b
9. Interferon beta-1b treatment modulates TNFα and IFNγ spontaneous gene expression in MS
10. Interferon beta induces interleukin-10 expression: relevance to multiple sclerosis
11. Interferon (IFN)-β treatment enhances CD95 and interleukin 10 expression but reduces interferon-γ producing T cells in MS patients
12. Immunomodulatory effects of interferon-β-1b in vivo: induction of the expression of transforming growth factor-β1 and its receptor type II
13. Interferon β-1b effects on cytokine mRNA in peripheral mononuclear cells in multiple sclerosis
14. Influence of IFNβ1b (Betaferon) on cytokine mRNA profiles in blood mononuclear cells and plasma levels of soluble VCAM-1 in multiple sclerosis
15. Glucocorticoids increase IL-10 expression in multiple sclerosis patients with acute relapse
16. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction
17. In vivo effects of interferon beta-1a on the immunosuppressive cytokines in multiple sclerosis
18. Blood levels of transforming growth factor-beta 1 (TGF-β1) are elevated in both relapsing remitting and chronic progressive multiple sclerosis (MS) patients and are further augmented by treatment with interferon beta (IFNβ1b)